These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35982253)
21. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu Li X; Wang W; Dong X; Sun Y J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783 [TBL] [Abstract][Full Text] [Related]
22. Coassembled Chitosan-Hyaluronic Acid Nanoparticles as a Theranostic Agent Targeting Alzheimer's β-Amyloid. Wang W; Liu M; Gao W; Sun Y; Dong X ACS Appl Mater Interfaces; 2021 Dec; 13(47):55879-55889. PubMed ID: 34786930 [TBL] [Abstract][Full Text] [Related]
23. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518 [TBL] [Abstract][Full Text] [Related]
24. Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10. Singh K; Kaur A; Goyal D; Goyal B Phys Chem Chem Phys; 2022 Sep; 24(36):21975-21994. PubMed ID: 36069400 [TBL] [Abstract][Full Text] [Related]
26. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils. Gu L; Guo Z J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382 [TBL] [Abstract][Full Text] [Related]
27. Light-Induced Chiral Iron Copper Selenide Nanoparticles Prevent β-Amyloidopathy In Vivo. Zhang H; Hao C; Qu A; Sun M; Xu L; Xu C; Kuang H Angew Chem Int Ed Engl; 2020 Apr; 59(18):7131-7138. PubMed ID: 32067302 [TBL] [Abstract][Full Text] [Related]
28. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein. Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742 [TBL] [Abstract][Full Text] [Related]
29. Suppression of Oligomer Formation and Formation of Non-Toxic Fibrils upon Addition of Mirror-Image Aβ42 to the Natural l-Enantiomer. Dutta S; Foley AR; Warner CJA; Zhang X; Rolandi M; Abrams B; Raskatov JA Angew Chem Int Ed Engl; 2017 Sep; 56(38):11506-11510. PubMed ID: 28682473 [TBL] [Abstract][Full Text] [Related]
30. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data. Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985 [TBL] [Abstract][Full Text] [Related]
31. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. Kreutzer AG; Nowick JS Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987 [TBL] [Abstract][Full Text] [Related]
32. A traditional Chinese Medicine, YXQN, Reduces Amyloid-induced Cytotoxicity by Inhibiting Aβ42 Aggregation and Fibril Formation. Wang L; Liu S; Xu J; Watanabe N; Di J; Wei W; Mayo KH; Li J; Li X Curr Pharm Des; 2020; 26(7):780-789. PubMed ID: 32031066 [TBL] [Abstract][Full Text] [Related]
33. Tin oxide nanoparticles trigger the formation of amyloid β oligomers/protofibrils and underlying neurotoxicity as a marker of Alzheimer's diseases. Jaragh-Alhadad LA; Falahati M Int J Biol Macromol; 2022 Apr; 204():154-160. PubMed ID: 35124024 [TBL] [Abstract][Full Text] [Related]
34. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide. Kim W; Hecht MH Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501 [TBL] [Abstract][Full Text] [Related]
35. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides. Wang L; Eom K; Kwon T Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350 [TBL] [Abstract][Full Text] [Related]
36. Effect of chitosan with different molecular weight on the stability, antioxidant and anticancer activities of well-dispersed selenium nanoparticles. Chen W; Yue L; Jiang Q; Xia W IET Nanobiotechnol; 2019 Feb; 13(1):30-35. PubMed ID: 30964034 [TBL] [Abstract][Full Text] [Related]
37. Enantiomers of cysteine-modified SeNPs (d/lSeNPs) as inhibitors of metal-induced Aβ aggregation in Alzheimer's disease. Zhou X; Sun J; Yin T; Le F; Yang L; Liu Y; Liu J J Mater Chem B; 2015 Oct; 3(39):7764-7774. PubMed ID: 32264585 [TBL] [Abstract][Full Text] [Related]
38. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling. Gu L; Tran J; Jiang L; Guo Z J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680 [TBL] [Abstract][Full Text] [Related]
39. Hydroxylated Single-Walled Carbon Nanotubes Inhibit Aβ Liu F; Wang W; Sang J; Jia L; Lu F ACS Chem Neurosci; 2019 Jan; 10(1):588-598. PubMed ID: 30335950 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, characterization, in vitro antioxidant and hypoglycemic activities of selenium nanoparticles decorated with polysaccharides of Gracilaria lemaneiformis. Tang L; Luo X; Wang M; Wang Z; Guo J; Kong F; Bi Y Int J Biol Macromol; 2021 Dec; 193(Pt A):923-932. PubMed ID: 34728301 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]